Media banner

Video &  Social Media

Watch us in interviews. Follow us.

 

News 2017

List of articles in category News 2017
Title Created Date
Q BioMed Provides Year End Update Dec 21, 2017
Q BioMed Announces Full Settlement of All Convertible Debt Dec 05, 2017
Q BioMed Adds Boston University’s Dr. Tager-Flusberg to Advisory Committee Nov 28, 2017
Q Biomed looks to dust off shelved cancer pain drug Nov 14, 2017
Q Biomed Inc. Announces Funding to Technology Partner Mannin Research Inc. to Expand Product Pipeline Nov 14, 2017
Q BioMed Announces Identification and Production of New Proprietary Drug Candidate for Pediatric Nonverbal Disorder Oct 19, 2017
Q BioMed Announces Favorable Amendment to Debenture Financing Oct 12, 2017
Q BioMed Announces Launch of PainFreeCancer.com Website in Support of Non-Opioid Cancer Pain Drug Oct 05, 2017
Q BioMed Announces Development Partnership With Sphaera Pharma Sep 19, 2017
Q BioMed Inc. Closes $3,050,390 Equity Financing Aug 02, 2017
Q BIOMED INC. FINALIZES LICENSE AGREEMENT WITH OKLAHOMA MEDICAL RESEARCH FOUNDATION AND THE RAJIV GANDHI CENTRE FOR BIOTECHNOLOGY FOR NOVEL LIVER CANCER TREATMENT Jul 27, 2017
Q BIOMED INC. TO PRESENT AT THE SIXTH ANNUAL MARCUM MICROCAP CONFERENCE IN NEW YORK Jul 27, 2017
Q BioMed Announces Attendance at Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting Jun 09, 2017
Q BioMed Inc. to Present at the Sixth Annual Marcum Microcap Conference in New York Jun 14, 2017
Q BioMed Inc. Finalizes License Agreement With Oklahoma Medical Research Foundation and the Rajiv Gandhi Centre for Biotechnology for Novel Liver Cancer Treatment Jun 15, 2017
Q BioMed Inc. Finalizes License Agreement With Oklahoma Medical Research Foundation and the Rajiv Gandhi Centre for Biotechnology for Novel Liver Cancer Treatment Jun 15, 2017
Q BioMed Inc. Adds Nuclear Medicine Industry Veteran to Commercialization Team Jun 26, 2017
Q Biomed Announces Licensing Agreement for Development of Drug to Treat Rare Pediatric Disorder New Treatment in Development Looks to Treat Rare Condition that Robs Approximately 20,000 US Children per Year of their Ability to Speak Apr 25, 2017
Q BioMed Inc. Announces Mannin Research Accepted Into Johnson & Johnson Innovation, JLABS @ Toronto Feb 02, 2017
Q Biomed Joins with Oklahoma Medical Research Foundation and Rajiv Gandhi Centre for Biotechnology to Develop Liver Cancer Chemotherapeutic Feb 07, 2017
Q BioMed Inc. to Present at Biotech Showcase 2017 in San Francisco Jan 9 – 11th Management reviews 2016 and looks ahead to 2017 Jan 05, 2017